Postoperative radiotherapy for pathological stage IIIA‐N2 non‐small cell lung cancer with positive surgical margins-Reference-Cited by-同舟云学术

Postoperative radiotherapy for pathological stage IIIA‐N2 non‐small cell lung cancer with positive surgical margins

Published:2020-11-27 Issue:2 Volume:12 Page:227-234
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Yuan Meng¹^ORCID,Men Yu²,Kang Jingjing¹,Sun Xin¹,Zhao Maoyuan¹,Bao Yongxing¹,Yang Xu¹,Sun Shuang¹,Ma Zeliang¹,Wang Jianyang¹,Deng Lei¹^ORCID,Wang Wenqing¹,Zhai Yirui¹,Liu Wenyang¹,Zhang Tao¹,Wang Xin¹,Bi Nan¹,Lv Jima¹,Liang Jun¹,Feng Qinfu¹,Chen Dongfu¹,Xiao Zefen¹,Zhou Zongmei¹,Wang Luhua¹,Hui Zhouguang¹²^ORCID

Affiliation:

1. Department of Radiation Oncology

2. Department of VIP Medical Services, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China

Funder

National Key Research and Development Program

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13749

Reference26 articles.

1. Impact of Adjuvant Treatment for Microscopic Residual Disease After Non-Small Cell Lung Cancer Surgery

2. Microscopic Residual Disease After Resection for Lung Cancer: A Multifaceted but Poor Factor of Prognosis

3. Prevalence, Prognostic Implications, and Survival Modulators of Incompletely Resected Non–Small Cell Lung Cancer in the U.S. National Cancer Data Base